Biotech Week articles from January 2003

Biotech Week archives from January 2003

New drug significantly improves survival even for patients with late-stage disease.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Gleevec, the new antileukemia drug from Novartis Pharmaceuticals, achieves a marked improvement in survival even for patients in the accelerated phase of chronic myeloid leukemia (CML), according to a...

Scientists describe revolutionary new test to help eliminate TB.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- A revolutionary new test for identifying people infected with tuberculosis (TB), one of the leading causes of death worldwide, will shortly be launched by Oxford Immunotec, Ltd., a new Oxford University...

Bupropion promotes weight loss, which then enhances mood.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Obese adults with depressive symptoms who received bupropion while following a restricted-calorie diet lost more weight than similar patients who...

G17DT safe in phase II clinical trials and increases survival of pancreatic cancer patients.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Phase II clinical trial results indicate that a vaccine containing the compound, G17DT, which causes the production of anti-gastrin antibodies,...

Orally active inhibitor of EGF signaling has potential for cancer therapy.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- AstraZeneca Pharmaceutical researchers report the company's product, Iressa, taken orally once daily, may have therapeutic application against tumors. "The epidermal growth factor receptor (EGFR)...

Mamu-A*01 allele has protective effect in animals.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a genetic factor that protects primates against AIDS. Zhi-Qiang Zhang and colleagues working at Merck...

Novel agents offer less-toxic hydroxyurea alternatives.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A pair of novel agents may represent less-toxic alternatives to hydroxyurea for HIV patients, researchers say. "Recently, the use of the ribonucleotide...

Positive results reported from first phase III clinical trial with indiplon-IR.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Neurocrine Biosciences, Inc., (NBIX) announced positive results from the company's first phase III clinical trial with indiplon-IR capsules, achieving both primary and secondary endpoints of sleep...

FDA clears COBAS Ampliscreen system.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Roche Diagnostics, based in Indianapolis, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the company's COBAS AmpliScreen System. The COBAS...

Gene test could identify diabetic patients most at risk.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Heart disease is the most frequent, costly and severe complication of diabetes, affecting more than 70% of diabetic patients, yet there are geographic and ethnic differences in the risk of diabetic...

Cell therapies company enters stock purchase agreement.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) has entered into a common stock purchase agreement with Fusion Capital Fund II, LLC, a Chicago-based institutional investor. Under the agreement, Fusion Capital...

Drug discovery deal targets natural product-based therapeutics.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) and MerLion Pharmaceuticals Pte., Ltd., a Singapore-based drug discovery company announced a collaboration for the discovery of natural product-based drugs for use in a broad...

AP5280 was well tolerated at platinum doses in phase I trial.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) announced the commencement of the next phase in the clinical development of Polymer Platinate AP5280. In addition, the company released a summary of the phase I...

Drug discovery labs expanded.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals announced the opening of additional drug discovery laboratories, including a state-of-the-art chemistry laboratory, to accommodate the company's expanding programs to discover...

Routine screening may not improve outcomes.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Although screening for prostate cancer is a common part of a routine checkup for American men, a new finding issued from the U.S. Preventive Services Task Force concludes there is insufficient...

Annual meeting postponed to revise proxy materials.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN) announced that it postponed its annual meeting of shareholders, previously announced for December 19, 2002, until after the first of the new year. The additional time is...

Series E financing yields $7.3M for medical device reprocessor.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Alliance Medical Corporation (Alliance), a reprocessor of medical devices, announced that it has received $7.3 million in new funding, positioning the company for continued growth. The Series E...

Poll shows new opportunity for partnership on key healthcare issues.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- The latest in a series of American Association of Health Plans (AAHP) postelection surveys reveals a significant shift in voter priorities on healthcare, particularly with respect to HMO reform. ...

Amerigroup receives approval for its Florida acquisition.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Amerigroup Corporation (AMGP) announced that it has received approval from the Florida Department of Insurance for its previously announced acquisition of PHP Holdings, Inc., and its wholly owned...

Insurer ending specialist requirement for some members.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Beginning in 2003, health insurer Anthem, Inc. will no longer require many of its members in Indiana, Kentucky and Ohio to get approval from their family doctor before seeing a specialist. Anthem...

Chest physician raises concerns over asthma drug for children.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- A consultant chest physician who has worked on a scientific paper published in the journal Archives of Childhood Disease, said that the study has revealed an "unexpected and alarming frequency of a...

Terms of research collaboration expanded to include new CNS target.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Argenta Discovery, Ltd., announced that it has extended its existing lead optimization project with H. Lundbeck A/S, in which Argenta is optimizing lead compounds within one of Lundbeck's central...

Ability to cope may play role in cancer progression.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- A review of the mind-body connection in breast cancer patients reveals that the stress of the diagnosis may make the disease worse but also suggests that good coping style may aid treatment and outcome....

Third round funding raises $2.1M.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Arryx, Inc., a company that provides laser-based systems for applications in the agricultural, pharmaceutical, and biotech industries, announced that it has completed a $2.1 million third round of...

New research promises cure by mouth.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- A researcher at Aston University in Birmingham has become the first in the U.K. to investigate a new type of vaccination delivery that could revolutionize how we are protected against diseases including...

New Lovenox data presented at hematology gathering.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Aventis has announced that new data supporting the efficacy and safety of Lovenox (enoxaparin sodium injection) for the prophylaxis and treatment of venous thromboembolic disease (VTE) was presented at...

Researchers study link between asthma, allergic rhinitis.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Aventis (AVE) released new information on the most comprehensive research program to date to study prescription seasonal allergy antihistamine Allegra (fexofenadine HCl). Aventis is working to...

FDA clears use of GuideLines 6.0 Rules.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Bayer Corporation, acting through its Diagnostics Business Group, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for GuideLines 6.0 Rules, the next-generation...

Court denies requests for stay of injunction in stent dispute.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that the U.S. Court of Appeals for the Seventh Circuit has denied requests by Cook, Inc., and Guidant Corporation for a stay of the permanent injunction...

Net sales increase to $37.4M-$38M.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX), released upward guidance for estimated net sales and earnings per share for the year 2002. These new projections are based on continued significant net sales...

Higher cost sharing reduces plans' drug expenditures but boosts enrollee costs.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Employer health plans that charge retirees higher copayments for retail pharmaceuticals saved themselves 18.7% per member on average in 2001, but their enrollees on average had 59.4% higher...

Higher body mass index a risk for men.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Increasing body mass index (BMI) is associated with a higher risk of stroke, according to a new study from Tobias Kurth, MD, of Brigham and Women's Hospital, Boston, and colleagues. The researchers...

Peter van Hoorn named president, biopharmaceutical business unit.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Cambrex Corp. (CBM) announced that Peter van Hoorn has been appointed president, Cambrex biopharmaceutical business unit. He will report to the office of the chairman. van Hoorn joins Cambrex...

Senior member of management leaves.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- CareScience, Inc., (CARE), a care management company, announced that Steven Bell, CareScience's chief financial officer is leaving the company to assume a similar position at another company. A...

Thalidomide-like compound shows early promise.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- A drug similar to thalidomide has been found to be promising with fewer side effects for treating patients with recurrent multiple myeloma, an incurable form of bone marrow cancer, according to early...

CDP 870 phase III milestone payment received from Pharmacia.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Celltech Group plc (CLL) announced that it has received a $10 million milestone payment from Pharmacia Corporation (PHA), relating to the initiation of phase III clinical development with CDP 870 in...

Heart valve business to be sold for $116M.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Centerpulse, Ltd., (CEP) announced that it has entered into a definitive agreement to sell its Carbomedics and Mitroflow mechanical and tissue heart valve business to Italian medical device company Snia...

CDC guidelines to help labs enforce 'biosecurity'.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- The U.S. government has issued detailed guidelines aimed at tightening security at labs that handle dangerous pathogens but have gone largely unregulated. It's the most detailed set of...

Federal scientists battle to unlock the secrets of deadly virus.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Giant beakers filled with blood clutter countertops and extra refrigerators cramp the hallways at the U.S. government's main research center for West Nile virus. Centers for Disease Control and...

Study finds ethnicity link.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Hispanic women contract cervical cancer almost twice as often as other women, indicating that not enough of them are having Pap tests, U.S. health officials say. The study by the Centers for...

Next generation Smart Cycler II launched.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD) announced the launch of its next generation real-time DNA analysis system, the Smart Cycler II. The Smart Cycler system, which has become a standard real-time analysis instrument for...

SURG II announces merger agreement.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Minnesota-based SURG II, Inc., (SURG) announced that it has entered into an agreement to merge with privately held Chiral Quest, LLC. Under the terms of the agreement, the two companies will...

Gene delivery company reports net loss of $0.10 per common share.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Chromos Molecular Systems, Inc., announced third quarter financial results for the period ended September 30, 2002. "Chromos' achievements for this past quarter reflect our previously announced...

Settlement offers step toward curbing abusive insurance practices.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- The following statement is attributable to Yank D. Coble, Jr., MD, American Medical Association (AMA) president: The decision by Cigna Corp. to settle a class-action lawsuit by agreeing to be more...

ClearOne audio equipment chosen for CDC emergency operations center.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Audio products from ClearOne Communications, Inc., (CLRO) will be installed in the U.S. Centers for Disease Control and Prevention's new Emergency Operations Center in Atlanta. The Emergency...

Seely named vice president of clinical research.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Corgentech, Inc., a privately held biotechnology company, announced that Lynn Seely, MD, has been appointed vice president of clinical research. Seely joins Corgentech from Cytyc Health Corporation...

Coriell Institute ships first unit for transplantation.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- The Coriell Institute for Medical Research's New Jersey Cord Blood Bank (NJCBB) has been approved as a National Marrow Donor Program member and it has recently shipped its first umbilical cord blood...

Share purchase agreement announced.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Cortex Systems, Inc., (CTXY) a U.S.-based healthcare company, announced it has formally executed a Share Purchase Agreement that allows for the Acquisition and Purchase of Nevada based R&D Trans Dermal...

$2.1M clinical consulting contracts announced.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced the signing of $2.1 million of clinical consulting contracts with several leading pharmaceutical companies. These contracts cover a wide range of therapeutic...

Research management company reports 31% increase in net revenue.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Covalent Group, Inc., (CVGR) announced results for the third quarter and 9 months ended September 30, 2002. Net revenue for the 3 months ended September 30, 2002 increased 31% to $6.0 million as...

Bone morphogenic protein technology licensed to Ortho Biotech.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced it has licensed its broad bone morphogenetic protein (BMP) technology portfolio to Ortho Biotech Products, L.P., a member of the Johnson & Johnson family of companies. ...

Dialysis services company approves shareholder rights plan.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- DaVita, Inc., (DVA) announced that its board of directors approved a shareholder rights plan. The board approved the declaration of a dividend distribution of one common share purchase right on...

Cancer's deadly signature revealed by gene chip technology.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Cancerous tumors can lie dormant within the human body for many years without harmful effect. And then, without warning, the cancer can grow and spread throughout the body, which usually leads to death....

Drug that boosts blood cell production reduces transfusions in critically ill.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Critically ill patients who received weekly administration of recombinant human erythropoietin (rHuEPO, which stimulates the body to produce new red blood cells) lowered their likelihood of receiving a...

Screening guidelines support HPV testing.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Digene Corporation (DIGE) announced that the American Cancer Society (ACS) has issued new cervical cancer screening guidelines including a preliminary recommendation that human papillomavirus (HPV) DNA...

Second installment payment completed to OXO Chemie AG purchase.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Dimethaid Research, Inc., (TSX: DMX) announced that, pursuant to its May 15th purchase agreement with Swiss-based OXO Chemie AG, the company elected to pay the November 30th installment of US$4.5...

Enzyme development collaboration signed.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Direvo Biotech AG and Danisco A/S announced the signing of a collaboration agreement under which both parties will develop an industrial enzyme. Under the terms of the agreement, Danisco will obtain...

Biotech company raises EUR 10.5M.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Direvo Biotech AG announced that it has raised EUR 10.5 million in its Series B equity financing. Direvo applies its integrated proprietary technologies to the development of better...

License, development agreement struck with Mimotopes.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Discovery Partners International, Inc., (DPII) and Mimotopes Pty., Ltd., a subsidiary of Fisher Scientific International, Inc., (FSH), announced that they have entered into a multiyear agreement under...

President departs as part of streamlining company operations.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced the continued streamlining of its operations, allowing the company to focus on the broader application and outlicensing of its core eligen technology...

Efficacy of calcitonin in treatment of postmenopausal osteoporosis confirmed.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- The European Union's Committee for Propriety Medicinal Products (CPMP) has confirmed the efficacy of calcitonin containing products in the treatment of osteoporosis, following an Article 31 Referral....

Williams named senior vice president, manufacturing.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Eyetech Pharmaceuticals, Inc., a privately held biotechnology company dedicated to the discovery, development, and commercialization of novel drugs for the treatment of eye disease, announced the...

Reduction strategies show success.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- People who use nicotine replacement products like skin patches, gum and inhalers while continuing to smoke can cut their daily cigarette consumption almost in half, according to a new study. Using...

Application submitted to market Lexapro for new indication.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration to expand the labeling of Lexapro (escitalopram...

FDA approves generic approval for Econazole Nitrate Cream.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Fougera, a division of Altana, Inc., has received FDA approval for Econazole Nitrate Cream 1% (Rx). This topical antifungal medication is AB-rated to Spectazole by Ortho Dermatological, and is...

Hormone replacement therapy link found.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- There is more evidence that progestin included in hormone replacement therapy (HRT) is linked to breast cancer. Postmenopausal women taking combined formulas of hormone replacement therapy that...

Posttranslant delirium common in cancer patients.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Cancer patients treated with stem cell grafts often have delirious episodes after transplantation, researchers in the United States warn. "Delirium is...

New theory opens perspectives on mental illness.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Worldwide, over 50 million people suffer from schizophrenia, a serious psychiatric disorder that generally appears from early adulthood. Medication can reduce the symptoms, such as delusions and...

Phase I trial initiated to test AdPEDF.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC) announced the commencement of a phase I clinical trial for its ophthalmology product candidate, AdPEDF, in patients with age-related macular degeneration (AMD). A total of up...

Americans deeply divided about use of genetic technologies in reproduction.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Americans are both hopeful and fearful about the rapidly advancing power of scientists to manipulate human reproduction, according to a new survey released by the Genetics and Public Policy Center, a...

Genitope initiates clinical trial to evaluate GTOP-99 following use of Rituxan.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Genitope Corp. announced the initiation of a clinical trial to evaluate the use of GTOP-99, a personalized vaccine-like immunotherapy, following treatment with Rituxan (rituximab) for patients...

Notice of termination of ADR facility announced.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Genset S.A. announced that, following Serono's recent tender offers and the subsequent delisting of Genset's American Depositary Shares (ADSs) from Nasdaq, it is terminating its American Depositary...

CRE-decoy aptamer showed significant activity in hormone-resistant breast cancer.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Genta Incorporated (GNTA) announced the presentation and publication of new data that show broad genomic and preclinical anticancer activity of one of the company's key pipeline products, the CRE-decoy...

New test quickly identifies both surface and e antigen of hepatitis B.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new test evaluated by researchers in Ghent, Belgium can quickly and accurately identify hepatitis B virus (HBV) surface and e antigen. The test can...

Mycobacterium tuberculosis H37Rv transposon library created.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Researchers at pharmaceutical giant GlaxoSmithKline have created a library of Mycobacterium tuberculosis insertional mutants generated with the transposon Tn5370." "The junction sequence between...

Lotronex Tablets now available for women with severe diarrhea-predominant IBS.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Lotronex (alosetron hydrochloride) Tablets will now be available under restricted conditions of use, which include a narrower indication for specific use in female patients with severe...

Price increase enacted to ensure supply meets demand.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Great Lakes Chemical Corporation (GLK) announced that effective December 15, 2002, where contracts allow, the price for Lowinox CPL hindered phenolic antioxidant will increase by 12% globally. The...

Synaptic agrees to be acquired by Denmark-based company.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Synaptic Pharmaceutical Corp. (SNAP), announced that it has signed a definitive merger agreement with H. Lundbeck, A/S, a Denmark-based international pharmaceutical company, by which Lundbeck will...

NDA filed for palonosetron.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Helsinn Healthcare SA, a privately-owned Swiss pharmaceutical group, announced that the U.S. Food and Drug Administration (FDA) has accepted their new drug application (NDA) for filing. The NDA was...

Breast diagnostics company expands relationship with Premier.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX), announced it signed an amendment of its contract with Premier, one of the nation's foremost purchasing and supply chain management organizations, for the purchase and sale of the...

Human serum albumin-interferon-alpha fusion protein studied.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- Human Genome Science Inc. recently presented pharmacokinetic and pharmacodynamic data on its human serum albumin-interferon-alpha fusion protein, Albuferon. Study authors B.L. Osborn and colleagues...

PharmaLinks wins 1 million pounds funding for antiobesity drug research.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- PharmaLinks, a collaborative initiative between the Universities of Glasgow and Strathclyde, has won a 1 m pounds research contract from Hyundai Pharmaceutical (Korea) to develop an antiobesity drug...

SEC charges settled.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals, Inc., (ICN) announced that it has settled a civil lawsuit filed in 1999 by the U.S. Securities and Exchange Commission regarding alleged violations of securities laws nearly 8 years...

FluINsure vaccine challenge trial started.
January 1, 2003... 2003 JAN 1 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that it has begun a human influenza challenge trial of its intranasally delivered FluINsure vaccine. The clinical trial site began intranasal immunization of study subjects...